Review that found PIP implants to be safe was flawed, say campaignersBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f3034 (Published 09 May 2013) Cite this as: BMJ 2013;346:f3034
- Jacqui Wise
Environmental campaigners have raised further concerns about silicone breast implants manufactured by the French company Poly Implant Prothèse (PIP), saying that they contained an endocrine disrupting chemical that at low doses could damage developing fetuses.
Their article in the Journal of the Royal Society of Medicine said that the silicone in the PIP implants had a higher proportion of small sized siloxane molecules D4, D5, and D6 than the norm. It said that even low doses of D4 (octamethylcyclotetrasiloxane) could affect a developing fetus.1
The article disagreed with the conclusion of the expert group chaired by the NHS’s medical director, Bruce …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial